RxDoctor Payments DataLook up a doctor →

William Merhi, DO

Interventional Cardiology · Grand Rapids, MINPI 1386786044

Payments from drug & device makers

$1,976,497in general payments, 2019–2025

Across 589 payments — averaging $3355.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1.5M
  • Boston Scientific$492K
  • Abbott$15K
  • Edwards Lifesciences$3K
  • Ancora Heart, Inc.$1K
  • Livanova USA, Inc.$79
  • plus $56 from 1 others

What the payments were for

  • Royalty or licence$8,9988%
  • Speaking & faculty fees$86,50076%
  • Travel & lodging$9,8429%
  • Food & beverage$8,8998%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)499$1,464,864
Boston Scientific37$492,496
Abbott34$14,811
Edwards Lifesciences13$2,814
Ancora Heart, Inc.4$1,378
Livanova USA, Inc.1$79
Baxter Healthcare1$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,976,497 in reported general payments places this provider in the 95th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan

Medicare billing

Part B allowed, 2024
$102,345
Medicare patients
174
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$10,501
Prednisone24$28
Amoxicillin16$14

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →